Advancing therapeutics in human immunodeficiency virus-associated lymphoma: where to go from here?
Metabolism Branch, National Cancer Institute, Bethesda, MD 20892, USA. dunleavk@mail.nih.gov
Kieron
K
Dunleavy
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000628:therapy*; D008297:Male; D017063:Outcome Assessment, Health Care / Q000379:methods*; D033581:Stem Cell Transplantation / Q000379:methods*